Tacrolimus Capsule
Product Images NDC 51079-028

7 FDA label images from Mylaninstitutional Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 51079-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylaninstitutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tacrolimus 0.5 mg Capsules Unit Carton Label (Image 01)

Tacrolimus 0.5 mg Capsules Unit Carton Label (Image 01)
Tacrolimus Capsules USP 0.5 mg oral capsules by Mylan Institutional Inc. The label shows the product name, dosage strength, images of the capsule marked with MYLAN 2045 and MYLAN 2046, and package quantity of 100 capsules (10 x 10). Storage instructions specify 20° to 25°C (68° to 77°F) controlled room temperature with light protection.*
FDA Label Image

Tacrolimus 1 mg Capsules Unit Carton Label (Image 02)

Tacrolimus 1 mg Capsules Unit Carton Label (Image 02)
Unit-dose packaging label for Tacrolimus oral capsules by Mylan Institutional Inc. The blue label includes usage warnings, institutional use only, child-resistant information, and a window for lot number and expiration date. The distributor address in Rockford, IL is also present.*
FDA Label Image

Tacrolimus 5 mg Capsules Unit Carton Label (Image 03)

Tacrolimus 5 mg Capsules Unit Carton Label (Image 03)
Tacrolimus 1 mg capsules, USP oral dosage form shown in two label sections from MylanInstitutional Inc. The top section features the product name, strength, and capsule imprint MYLAN 2046. The bottom section repeats this information with a barcode, prescription-only notation, and storage instructions. The label also notes packaging of 100 capsules (10 x 10) and lists the manufacturer as Mylan Pharmaceuticals Inc., Morgantown, WV.*
FDA Label Image

Tacrolimus Structural Formula (Image 04)

Tacrolimus Structural Formula (Image 04)
Chemical structure diagram of the active ingredient Tacrolimus, depicting its molecular configuration including various functional groups and stereochemistry as typically represented in pharmaceutical labeling.*
FDA Label Image

Serialized Unit Carton (Image 05)

Serialized Unit Carton (Image 05)
Packaging label for Tacrolimus oral capsules by Mylan Institutional Inc., featuring a blue unit-dose container. The label includes warnings that the package is not child-resistant, intended for institutional use, and offers light resistance. It also displays the Mylan logo and a window for lot number and expiration date.*
FDA Label Image

Serialized Unit Carton (Image 06)

Serialized Unit Carton (Image 06)
Label for Tacrolimus Capsules, USP, 5 mg oral capsules by MylanInstitutional Inc. The label displays the drug name, strength 5 mg, capsule images marked MYLAN 2047, and packaging information for 100 capsules (10 x 10). Storage instructions and manufacturer details from Mylan Pharmaceuticals, Morgantown, WV, are also included.*
FDA Label Image

Serialized Unit Carton (Image 07)

Serialized Unit Carton (Image 07)
Packaging label for Tacrolimus capsules by Mylan Institutional Inc., showing a blue unit-dose package designed for institutional oral use. The label includes warnings about child resistance, drug safety, and a window for lot number and expiration date. The Mylan logo and distributor information from Rockford, IL, are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.